151 related articles for article (PubMed ID: 32691330)
1. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients?
Al-Hasan MN; Al-Jaghbeer MJ
Drugs Aging; 2020 Sep; 37(9):627-633. PubMed ID: 32691330
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
3. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
4. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
5. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
Brownridge DJ; Zaidi STR
J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
[TBL] [Abstract][Full Text] [Related]
6. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
Canut A; MartÃn-Herrero JE; Labora A; Maortua H
J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
[TBL] [Abstract][Full Text] [Related]
7. In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study.
Vanoverschelde A; Van Hoey C; Buyle F; Den Blauwen N; Depuydt P; Van Braeckel E; Lahousse L
BMC Pulm Med; 2023 Apr; 23(1):138. PubMed ID: 37098509
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study.
Ernst P; Dahl M; Chateau D; Daneman N; Quail J; Sketris IS; Fisher A; Zhang J; Bugden S;
Int J Chron Obstruct Pulmon Dis; 2019; 14():2939-2946. PubMed ID: 31908442
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Qian W; Huang GZ
Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
[TBL] [Abstract][Full Text] [Related]
13. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
[TBL] [Abstract][Full Text] [Related]
14. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis.
Cui Y; Luo L; Li C; Chen P; Chen Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():3813-3829. PubMed ID: 30538443
[TBL] [Abstract][Full Text] [Related]
15. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
[TBL] [Abstract][Full Text] [Related]
17. Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study.
Wang Y; Bos JH; Boezen HM; Alffenaar JC; van Boven JFM; Schuiling-Veninga CCM; Wilffert B; Hak E
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 32075781
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis.
An X; Zhang C; Weng X; Xiao W; Sun Z; Zeng Z; Huang Q
Medicine (Baltimore); 2020 Jul; 99(29):e21152. PubMed ID: 32702869
[TBL] [Abstract][Full Text] [Related]
19. Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines Initiative.
Wang Y; Pera V; Boezen HM; Alffenaar JC; Wilffert B; Groenwold RHH; Hak E
Respiration; 2022; 101(6):553-564. PubMed ID: 34979502
[TBL] [Abstract][Full Text] [Related]
20. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
